NCT01684215 2020-11-23A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerPfizerPhase 2 Completed61 enrolled 45 charts
NCT04524728 2020-08-24Patterns of Treatment and Outcome of Palbociclib Plus Endocrine TherapyIstituti Clinici Scientifici Maugeri SpACompleted191 enrolled